Tata India Pharma and Healthcare Fund Direct Plan Growth vs Mirae Asset Nifty 500 Healthcare ETF
NAV, returns and costs — not a recommendation.
 Tata India Pharma and Healthcare Fund Direct Plan Growth |  Mirae Asset Nifty 500 Healthcare ETF | |
|---|---|---|
| NAV | ₹39.7747 | ₹21.4635 |
| NAV date | 2026-08-18 | 2026-08-19 |
| 1 year | +9.62% | +16.37% |
| 3 year (p.a.) | +20.31% | +16.37% |
| 5 year (p.a.) | +15.52% | +16.37% |
| Expense ratio | 0.67% | 0.12% |
| Fund size | ₹1,455.16 Cr | ₹12.06 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.